Rocket Pharmaceuticals (RCKT)
(Delayed Data from NSDQ)
$3.04 USD
-0.03 (-0.98%)
Updated Aug 5, 2025 04:00 PM ET
After-Market: $3.03 -0.01 (-0.33%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth C Momentum F VGM
Fundamental Charts
About Market Cap
As of the previous market close, Rocket Pharmaceuticals, Inc. has a market cap of $327.83M, which represents its share price of $3.07 multiplied by its outstanding shares number of 106.79M. As a small-cap company, RCKT's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
RCKT 3.04 -0.03(-0.98%)
Will RCKT be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for RCKT based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for RCKT
RCKT Stock Up on FDA's RMAT Tag to Gene Therapy for Heart Failure
RCKT's IND for RP-A701 in Dilated Cardiomyopathy Gets FDA Clearance
RCKT: What are Zacks experts saying now?
Zacks Private Portfolio Services
RCKT Stock Tanks on Patient Death in Danon Disease Study
RCKT's Q1 Loss Narrower Than Expected, Pipeline in Focus
Rocket Pharmaceuticals Q4 Loss Narrower Than Estimates, Pipeline in Focus
Other News for RCKT
Biotech stocks rise following Prasad exit from FDA
Biotech stocks rise following Prasad exit from FDA
Rocket Pharmaceuticals (RCKT) Target Price Revised, Strategic Focus Shifted | RCKT Stock News
Rocket Pharmaceuticals (RCKT) Downgraded by B of A Securities | RCKT Stock News
Rocket Pharmaceuticals price target lowered by $1 at Canaccord, here's why